THC Therapeutics Valuation Multiples

Discover THC Therapeutics' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like McPhy Energy, Greiffenberger, Cerinnov Group, INLIF Limited and more.

THC Therapeutics Overview

About THC Therapeutics

THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.


Founded

2007

HQ

United States

Employees

1

Website

thct.io

Sectors

Financials (FY)

Revenue: -
EBITDA: ($666K)

EV

$752K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

THC Therapeutics Financials

THC Therapeutics reported last fiscal year revenue of - and negative EBITDA of ($666K).

In the same fiscal year, THC Therapeutics generated - in gross profit, ($666K) in EBITDA losses, and had net loss of ($812K).


THC Therapeutics P&L

In the most recent fiscal year, THC Therapeutics reported revenue of - and EBITDA of ($666K).

THC Therapeutics is unprofitable as of last fiscal year, with gross margin of -, EBITDA margin of -, and net margin of -.

See analyst estimates for THC Therapeutics
Last FY20232024202620272028
EBITDA($666K)($456K)($666K)
Net Profit($812K)($564K)($812K)
Net Debt$732K--

Financial data powered by Morningstar, Inc.

THC Therapeutics Stock Performance

THC Therapeutics has current market cap of $19K, and enterprise value of $752K.

Market Cap Evolution


THC Therapeutics' stock price is $0.00.

THC Therapeutics share price decreased by 44.4% in the last 30 days, and increased by 400.1% in the last year.

THC Therapeutics has an EPS (earnings per share) of $-0.02.

See more trading valuation data for THC Therapeutics
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$752K$19K0.0%-44.4%-44.4%400.1%$-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

THC Therapeutics Valuation Multiples

THC Therapeutics trades at (1.1x) EV/EBITDA.

See NTM and 2027E valuation multiples for THC Therapeutics

THC Therapeutics Financial Valuation Multiples

As of July 19, 2026, THC Therapeutics has market cap of $19K and EV of $752K.

THC Therapeutics has a P/E ratio of (0.0x).

Last FY20232024202620272028
EV/EBITDA(1.1x)(1.6x)(1.1x)
EV/EBIT(1.4x)(1.5x)(1.4x)
P/E(0.0x)(0.0x)(0.0x)
EV/FCF(4.1x)(6.0x)(4.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified THC Therapeutics Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

THC Therapeutics Margins & Growth Rates

See estimated margins and future growth rates for THC Therapeutics

THC Therapeutics Growth Rates

23/2426/2727/2828/29
EBITDA Growth46%
EBIT Growth5%
Net Profit Growth44%
FCF Growth45%

Data powered by FactSet, Inc. and Morningstar, Inc.

THC Therapeutics Operational KPIs

THC Therapeutics' revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.5M for the same period.

Access forward-looking KPIs for THC Therapeutics
Last FY202620272028
Revenue per Employee$0.0M
Opex per Employee$0.5M

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

THC Therapeutics Competitors

THC Therapeutics competitors include McPhy Energy, Greiffenberger, Cerinnov Group, INLIF Limited, ECOMB, Composite Alliance Group, DBT and Avsalt Group.

Most THC Therapeutics public comparables operate across Machinery.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
McPhy Energy0.1x-(0.0x)-
Greiffenberger0.1x-(4.9x)-
Cerinnov Group0.4x-(5.2x)-
INLIF Limited(0.1x)-0.4x-
ECOMB2.3x-(0.5x)-
Composite Alliance Group1.0x-(5.1x)-

This data is available for Pro users. Sign up to see all THC Therapeutics competitors and their valuation data.

Start Free Trial

Acquisitions by THC Therapeutics

THC Therapeutics has acquired 1 company to date.

Last acquisition by THC Therapeutics was on July 9th 2025. THC Therapeutics acquired SugarTop Buddery for $3M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by THC Therapeutics

SugarTop Buddery
Description
SugarTop Buddery is a Vancouver-based cannabis dispensary specializing in craft flower strains and pre-rolled joints. The retailer sources products from licensed British Columbia cultivators like 7 Fingers and Broken Coast for indoor-grown indicas and sativas. SugarTop Buddery operates a physical store in East Vancouver with online ordering for recreational users aged 19 and older.
HQ CountryUnited States
HQ City
Eugene, OR
Deal Date9 Jul 2025
Valuation$3M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all THC Therapeutics acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About THC Therapeutics

When was THC Therapeutics founded?THC Therapeutics was founded in 2007.
Where is THC Therapeutics headquartered?THC Therapeutics is headquartered in United States.
How many employees does THC Therapeutics have?As of today, THC Therapeutics has over 1 employees.
Is THC Therapeutics publicly listed?Yes, THC Therapeutics is a public company listed on OTCM.
What is the stock symbol of THC Therapeutics?THC Therapeutics trades under THCT ticker.
When did THC Therapeutics go public?THC Therapeutics went public in 2007.
Who are competitors of THC Therapeutics?THC Therapeutics main competitors include McPhy Energy, Greiffenberger, Cerinnov Group, INLIF Limited, ECOMB, Composite Alliance Group, DBT, Avsalt Group.
What is the current market cap of THC Therapeutics?THC Therapeutics' current market cap is $19K.
Is THC Therapeutics profitable?No, THC Therapeutics is not profitable.
How many companies THC Therapeutics has acquired to date?As of July 2026, THC Therapeutics has acquired 1 company.
What was the largest acquisition by THC Therapeutics?$3M acquisition of SugarTop Buddery on 9th July 2025 was the largest M&A THC Therapeutics has done to date.
What companies THC Therapeutics acquired?THC Therapeutics acquired SugarTop Buddery.
In how many companies THC Therapeutics has invested to date?THC Therapeutics hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to THC Therapeutics

Lists including THC Therapeutics

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial